Atorvastatin Tablets IP 40 MG – Otovas 40 Tablets

Otovas 40 Tablets – Stronger Control for Severe Dyslipidemia.

Otovas 40 Tablets – Atorvastatin Tablets IP 40 MG provides high-intensity statin therapy for patients requiring aggressive lipid-lowering management:
Atorvastatin 40 mg – A potent HMG-CoA reductase inhibitor that reduces cholesterol synthesis in the liver, lowering LDL cholesterol and triglycerides while increasing HDL cholesterol. This stronger dose is prescribed for patients at high or very high cardiovascular risk to prevent heart attack and stroke.

Key Benefits of Atorvastatin 40 mg – Otovas 40 Tablets
✅ Intensive Lipid Reduction – Provides stronger LDL and triglyceride reduction with a proven increase in HDL levels.
✅ High-Risk Patient Protection – Lowers the risk of recurrent heart attacks, strokes, and cardiovascular deaths in severe dyslipidemia or existing cardiovascular disease.
✅ Trusted Long-Term Therapy – Well-established safety and efficacy in patients requiring aggressive cholesterol control.
✅ Pleiotropic Effects – Offers additional vascular protection through anti-inflammatory and antioxidant properties.

Recommended By Specialists:
👨‍⚕️ Cardiologists: For secondary prevention in post-myocardial infarction, stent placement, or established coronary artery disease.
👨‍⚕️ Internal Medicine Specialists / General Physicians: For patients requiring intensive lipid control.
👨‍⚕️ Endocrinologists: For high-risk diabetic patients to reduce cardiovascular complications.
👨‍⚕️ Neurologists: For recurrent stroke prevention associated with atherosclerosis.

INDICATIONS:
✅ Severe Hypercholesterolemia
✅ Mixed Dyslipidemia (elevated cholesterol + triglycerides)
✅ Secondary prevention post-MI, stroke, or coronary intervention
✅ High cardiovascular risk patients, including those with Type 2 Diabetes Mellitus
✅ Atherosclerotic Cardiovascular Disease (ASCVD) management